Lipid Nanoparticles white paper updated thumbnail

Lipid Nanoparticles: Past, Present, and Future Opportunities

Lipid nanoparticles were propelled into the global spotlight for their role in two approved COVID mRNA vaccines. However, lipid nanoparticles aren't unique, in fact their development started decades ago as liposomes and as critical drug delivery vehicles. Only now, has more and more opportunities for advancement and applications emerged.

Lipid Nanoparticles white paper cover

{{lipid-report="/new-components"}}

Download the CAS Insights Report

Related CAS Insights

Drug Discovery

A review of the global efforts on COVID-19 vaccine development

March 29, 2021

Read article
Drug Discovery

ACE2: Targeting a potentially important receptor in disease pathogenesis

December 15, 2022

Read article
Drug Discovery

ACS webinar on molecular glues and targeted protein degradation

October 12, 2022

Read article

Gain new perspectives for faster progress directly to your inbox.